Cargando…
Adjuvant Effect of IV Clodronate on the Delay of Bone Metastasis in High-Risk Prostate Cancer Patients: A Prospective Study
PURPOSE: High-risk prostate cancer patients undergoing treatment often experience biochemical recurrence. The use of bisphosphonates as an adjuvant treatment delays skeletal events, yet whether or not bisphosphonates also delay metastastic development remains to be determined. MATERIALS AND METHODS:...
Autores principales: | Rodrigues, Paulo, Hering, Flavio O., Meller, Alex |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Cancer Association
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253865/ https://www.ncbi.nlm.nih.gov/pubmed/22247708 http://dx.doi.org/10.4143/crt.2011.43.4.231 |
Ejemplares similares
-
The stunning clodronate
por: Mass, Elvira
Publicado: (2023) -
Concomitant i.v. and oral clodronate in the relief of bone pain--a double-blind placebo-controlled study in patients with prostate cancer.
por: Kylmälä, T., et al.
Publicado: (1997) -
Clodronate improves bone mineral density in post-menopausal breast cancer patients treated with adjuvant antioestrogens.
por: Saarto, T., et al.
Publicado: (1997) -
Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026]
por: Powles, Trevor, et al.
Publicado: (2006) -
The boy who refused an IV: a case report of subcutaneous clodronate for bone pain in a child with Ewing Sarcoma
por: Siden, Harold
Publicado: (2007)